Verona Pharma (VRNA) PT Raised to $30 at Wedbush following ensifentrine data
Tweet Send to a Friend
Wedbush analyst Andreas Argyrides raised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
